US Stock MarketDetailed Quotes

TNON Tenon Medical

Watchlist
  • 2.190
  • -0.010-0.45%
Close Dec 4 16:00 ET
  • 2.230
  • +0.040+1.82%
Post 20:02 ET
6.87MMarket Cap-90P/E (TTM)

Tenon Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-6.04%887K
21.27%901K
66.05%719K
323.73%2.93M
191.70%808K
353.85%944K
450.37%743K
509.86%433K
331.88%691K
422.64%277K
Operating revenue
-6.04%887K
21.27%901K
66.05%719K
323.73%2.93M
191.70%808K
353.85%944K
450.37%743K
509.86%433K
331.88%691K
422.64%277K
Cost of revenue
14.67%469K
-21.49%431K
-48.13%249K
26.65%1.69M
-48.55%249K
35.43%409K
102.58%549K
74.55%480K
2,321.82%1.33M
2,747.06%484K
Gross profit
-21.87%418K
142.27%470K
1,100.00%470K
293.60%1.24M
370.05%559K
669.15%535K
242.65%194K
76.96%-47K
-710.48%-641K
-675.00%-207K
Operating expense
-7.16%3.63M
-3.85%4.34M
-17.83%3.98M
-6.17%16.97M
-52.08%3.7M
23.52%3.91M
-15.11%4.52M
158.08%4.84M
175.42%18.08M
197.19%7.72M
Selling and administrative expenses
-6.30%2.98M
0.53%3.63M
-17.43%3.31M
-9.51%13.81M
-56.45%3.01M
33.95%3.18M
-22.47%3.62M
205.03%4.01M
214.69%15.26M
282.77%6.91M
-Selling and marketing expense
-20.63%1.21M
-23.10%1.45M
-31.84%1.38M
-13.47%6.78M
-72.99%1.34M
136.74%1.53M
-3.09%1.88M
634.06%2.03M
265.86%7.83M
643.86%4.97M
-General and administrative expense
6.97%1.76M
26.21%2.19M
-2.68%1.93M
-5.33%7.03M
-14.07%1.67M
-4.46%1.65M
-36.32%1.73M
90.84%1.98M
174.21%7.42M
70.62%1.94M
Research and development costs
-10.85%657K
-21.42%708K
-19.78%669K
11.85%3.16M
-14.90%691K
-7.53%737K
37.14%901K
48.40%834K
64.61%2.83M
2.40%812K
Operating profit
4.83%-3.22M
10.41%-3.87M
28.24%-3.51M
16.01%-15.73M
60.38%-3.14M
-3.56%-3.38M
20.78%-4.32M
-135.02%-4.89M
-189.82%-18.73M
-209.45%-7.93M
Net non-operating interest income expense
0
0
-34K
94.07%-21K
-312.50%-17K
-4K
0
0
43.00%-354K
102.85%8K
Non-operating interest expense
--0
--0
--34K
-94.07%21K
312.50%17K
--4K
--0
--0
-43.00%354K
-102.85%-8K
Other net income (expense)
-38.00%31K
24.32%46K
-164.29%-36K
3.09%167K
60.00%24K
-45.05%50K
-33.93%37K
56K
16,100.00%162K
15K
Gain on sale of security
-38.00%31K
5.41%39K
-51.79%27K
-7.22%167K
-66.67%24K
-30.56%50K
5.71%37K
5,500.00%56K
8,900.00%180K
7,100.00%72K
Other non- operating income (expenses)
----
--7K
---63K
----
----
----
----
----
-1,700.00%-18K
---57K
Income before tax
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
17.63%-15.58M
60.35%-3.13M
-5.08%-3.33M
21.92%-4.29M
-105.27%-4.83M
-167.15%-18.92M
-178.15%-7.91M
Income tax
Net income
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
17.63%-15.58M
60.35%-3.13M
-5.08%-3.33M
21.92%-4.29M
-105.27%-4.83M
-167.15%-18.92M
-178.15%-7.91M
Net income continuous Operations
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
17.63%-15.58M
60.35%-3.13M
-5.08%-3.33M
21.92%-4.29M
-105.27%-4.83M
-167.15%-18.92M
-178.15%-7.91M
Minority interest income
Net income attributable to the parent company
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
17.63%-15.58M
60.35%-3.13M
-5.08%-3.33M
21.92%-4.29M
-105.27%-4.83M
-168.40%-18.92M
-178.15%-7.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.44%-3.18M
10.71%-3.83M
25.96%-3.58M
17.63%-15.58M
60.35%-3.13M
-5.08%-3.33M
21.92%-4.29M
-105.27%-4.83M
-168.40%-18.92M
-178.15%-7.91M
Basic earnings per share
68.95%-29.04
68.90%-8.16
70.93%-10
63.63%-68.72
84.37%-9.642
-314.54%-93.52
49.54%-26.24
-120.27%-34.4
-276.58%-188.96
-204.84%-61.68
Diluted earnings per share
68.95%-29.04
68.90%-8.16
70.93%-10
63.63%-68.72
84.37%-9.642
-314.54%-93.52
49.54%-26.24
-120.27%-34.4
-276.58%-188.96
-204.84%-61.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -6.04%887K21.27%901K66.05%719K323.73%2.93M191.70%808K353.85%944K450.37%743K509.86%433K331.88%691K422.64%277K
Operating revenue -6.04%887K21.27%901K66.05%719K323.73%2.93M191.70%808K353.85%944K450.37%743K509.86%433K331.88%691K422.64%277K
Cost of revenue 14.67%469K-21.49%431K-48.13%249K26.65%1.69M-48.55%249K35.43%409K102.58%549K74.55%480K2,321.82%1.33M2,747.06%484K
Gross profit -21.87%418K142.27%470K1,100.00%470K293.60%1.24M370.05%559K669.15%535K242.65%194K76.96%-47K-710.48%-641K-675.00%-207K
Operating expense -7.16%3.63M-3.85%4.34M-17.83%3.98M-6.17%16.97M-52.08%3.7M23.52%3.91M-15.11%4.52M158.08%4.84M175.42%18.08M197.19%7.72M
Selling and administrative expenses -6.30%2.98M0.53%3.63M-17.43%3.31M-9.51%13.81M-56.45%3.01M33.95%3.18M-22.47%3.62M205.03%4.01M214.69%15.26M282.77%6.91M
-Selling and marketing expense -20.63%1.21M-23.10%1.45M-31.84%1.38M-13.47%6.78M-72.99%1.34M136.74%1.53M-3.09%1.88M634.06%2.03M265.86%7.83M643.86%4.97M
-General and administrative expense 6.97%1.76M26.21%2.19M-2.68%1.93M-5.33%7.03M-14.07%1.67M-4.46%1.65M-36.32%1.73M90.84%1.98M174.21%7.42M70.62%1.94M
Research and development costs -10.85%657K-21.42%708K-19.78%669K11.85%3.16M-14.90%691K-7.53%737K37.14%901K48.40%834K64.61%2.83M2.40%812K
Operating profit 4.83%-3.22M10.41%-3.87M28.24%-3.51M16.01%-15.73M60.38%-3.14M-3.56%-3.38M20.78%-4.32M-135.02%-4.89M-189.82%-18.73M-209.45%-7.93M
Net non-operating interest income expense 00-34K94.07%-21K-312.50%-17K-4K0043.00%-354K102.85%8K
Non-operating interest expense --0--0--34K-94.07%21K312.50%17K--4K--0--0-43.00%354K-102.85%-8K
Other net income (expense) -38.00%31K24.32%46K-164.29%-36K3.09%167K60.00%24K-45.05%50K-33.93%37K56K16,100.00%162K15K
Gain on sale of security -38.00%31K5.41%39K-51.79%27K-7.22%167K-66.67%24K-30.56%50K5.71%37K5,500.00%56K8,900.00%180K7,100.00%72K
Other non- operating income (expenses) ------7K---63K---------------------1,700.00%-18K---57K
Income before tax 4.44%-3.18M10.71%-3.83M25.96%-3.58M17.63%-15.58M60.35%-3.13M-5.08%-3.33M21.92%-4.29M-105.27%-4.83M-167.15%-18.92M-178.15%-7.91M
Income tax
Net income 4.44%-3.18M10.71%-3.83M25.96%-3.58M17.63%-15.58M60.35%-3.13M-5.08%-3.33M21.92%-4.29M-105.27%-4.83M-167.15%-18.92M-178.15%-7.91M
Net income continuous Operations 4.44%-3.18M10.71%-3.83M25.96%-3.58M17.63%-15.58M60.35%-3.13M-5.08%-3.33M21.92%-4.29M-105.27%-4.83M-167.15%-18.92M-178.15%-7.91M
Minority interest income
Net income attributable to the parent company 4.44%-3.18M10.71%-3.83M25.96%-3.58M17.63%-15.58M60.35%-3.13M-5.08%-3.33M21.92%-4.29M-105.27%-4.83M-168.40%-18.92M-178.15%-7.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.44%-3.18M10.71%-3.83M25.96%-3.58M17.63%-15.58M60.35%-3.13M-5.08%-3.33M21.92%-4.29M-105.27%-4.83M-168.40%-18.92M-178.15%-7.91M
Basic earnings per share 68.95%-29.0468.90%-8.1670.93%-1063.63%-68.7284.37%-9.642-314.54%-93.5249.54%-26.24-120.27%-34.4-276.58%-188.96-204.84%-61.68
Diluted earnings per share 68.95%-29.0468.90%-8.1670.93%-1063.63%-68.7284.37%-9.642-314.54%-93.5249.54%-26.24-120.27%-34.4-276.58%-188.96-204.84%-61.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data